```html

Pyloric Stenosis in Infants

What is Pyloric Stenosis (infants)?

Pyloric stenosis is a condition that affects newborns and young infants in which the muscle at the outlet of the stomach (the pylorus) becomes abnormally thickened and tightens, narrowing the passage that allows food to move from the stomach into the small intestine. Because of this blockage, milk cannot pass normally, leading to forceful vomiting, dehydration, and weight loss. The condition most often appears between 2 and 8 weeks of age and is more common in first‑born males.

The medical term “infantile hypertrophic pyloric stenosis” (IHPS) reflects the underlying pathology: hypertrophy (enlargement) of the pyloric muscle. It is considered a benign anatomic problem, but if left untreated it can quickly become life‑threatening due to fluid loss and electrolyte disturbances.

Key points

• Onset: usually 2–8 weeks after birth.
• Gender: ~4 : 1 male to female ratio.
• Nature: non‑infectious, structural narrowing of the pyloric channel.

Common Causes

The exact cause of infantile pyloric stenosis is not fully understood, but research shows a combination of genetic, hormonal, and environmental factors. Below are the most frequently cited contributors.

• Genetic predisposition: A family history (especially a father or brother) increases risk by 2–3‑fold.
• Male sex: Hormonal differences in early infancy are thought to promote muscle growth.
• Prematurity or low birth weight: Infants born <37 weeks or weighing <2.5 kg have a higher incidence.
• Macrolide antibiotic exposure: Use of erythromycin (often given to treat pertussis) in the first two weeks of life is linked to a 2–5‑fold rise in risk.
• Rapid post‑natal weight gain: A sudden increase in feeding volume may stimulate pyloric muscle hypertrophy.
• Maternal smoking during pregnancy: Nicotine may affect fetal gastric muscle development.
• Blood type: Some studies suggest babies with blood type O may be slightly more prone.
• Electrolyte abnormalities in utero: Fetal exposure to abnormal calcium or potassium levels may predispose muscle overgrowth.
• Ethnic background: Higher rates observed in Caucasian infants compared with African‑American or Asian infants.
• Idiopathic: In many cases no clear trigger can be identified; the condition is considered “idiopathic”.

Associated Symptoms

Infants with pyloric stenosis often present with a recognizable “classic” picture, but symptoms can vary. Common accompanying findings include:

• Projectile vomiting: Forceful, non‑bilious (no bile) vomiting that may empty the stomach in seconds.
• Hungry after vomiting: The baby often appears eager to feed again.
• Weight loss or poor weight gain: Despite frequent feedings, the infant may fail to thrive.
• Dehydration: Dry mucous membranes, decreased urine output, and sunken fontanelle.
• Visible peristaltic waves: Rippling movements across the abdomen after a feed.
• Palpable “olive‑shaped” mass: A firm, mobile nodule in the right upper quadrant (the hypertrophied pylorus).
• Changes in stool: Typically normal, but may become infrequent due to reduced intake.
• Electrolyte imbalance: Low potassium (hypokalemia) and low chloride (hypochloremic metabolic alkalosis) develop as vomiting persists.

When to See a Doctor

Prompt evaluation is crucial. Contact a pediatrician or go to the emergency department if you notice any of the following:

• Frequent vomiting that is forceful or projectile.
• Vomiting that persists for more than 24 hours, especially if it is non‑bilious.
• Signs of dehydration: dry lips, no tears when crying, fewer wet diapers (≤ 4 per day).
• Rapid weight loss or failure to gain weight despite regular feedings.
• Visible “olive‑shaped” mass in the abdomen.
• Excessive irritability or lethargy.

Early assessment prevents complications such as severe electrolyte disturbances and hospitalisation.

Diagnosis

Diagnosis is based on a combination of history, physical examination, and imaging.

Clinical evaluation

• History: Onset of vomiting, feeding patterns, family history, antibiotic exposure.
• Physical exam: Palpation of the “olive” mass, observation of peristaltic waves, assessment of hydration status.

Imaging studies

• Ultrasound (first‑line): Highly sensitive (≈ 100 %) and specific. Shows a thickened pyloric muscle (> 3 mm) and an elongated pyloric channel (> 14 mm).
• Upper gastrointestinal (UGI) series: Used when ultrasound is inconclusive. Demonstrates delayed gastric emptying and a “string sign.”

Laboratory tests

• Basic metabolic panel to detect hypochloremic, hypokalemic metabolic alkalosis.
• Blood gas analysis if severe vomiting is present.

Differential diagnosis

Conditions that can mimic pyloric stenosis include gastroesophageal reflux disease, food allergies, intestinal malrotation, and congenital infections. Proper imaging helps distinguish these entities.

Treatment Options

The definitive cure for infantile pyloric stenosis is surgical, but supportive care before surgery is vital.

Initial medical management

• Fluid resuscitation: Intravenous (IV) normal saline or lactated Ringer’s solution to correct dehydration.
• Electrolyte correction: IV potassium chloride and bicarbonate as needed to reverse metabolic alkalosis.
• Nasogastric (NG) decompression: May be used to relieve gastric distention before surgery.

Surgical treatment

• Pyloromyotomy (Ramstedt procedure): The standard operation. The surgeon makes a longitudinal incision in the hypertrophied muscle and spreads the fibers, relieving the obstruction while leaving the mucosa intact.
• Open vs. Laparoscopic: Both have similar success rates (> 99 %). Laparoscopic pyloromyotomy offers smaller incisions and quicker recovery, but requires specialized expertise.
• Post‑operative care: Most infants begin feeding within 4–6 hours after surgery and can be discharged after 24–48 hours if hydration is stable.

Home care after discharge

• Resume normal breast‑milk or formula feeds; most babies tolerate regular volume within a day.
• Monitor weight daily for the first week.
• Watch for any resurgence of vomiting or signs of infection at the incision site.

Prevention Tips

Because many risk factors are non‑modifiable (genetics, sex), primary prevention focuses on reducing known environmental contributors.

• Avoid unnecessary erythromycin: Reserve macrolides for clear bacterial indications; discuss alternatives with the pediatrician.
• Maternal smoking cessation: Quitting smoking before or during pregnancy lowers the infant’s risk.
• Monitor growth in preterm infants: Provide tailored feeding plans to avoid rapid over‑feeding.
• Family counseling: If a sibling or parent had pyloric stenosis, inform the pediatrician so the baby can be examined more closely during early weeks.

Emergency Warning Signs

Summary

Infantile pyloric stenosis is a treatable yet potentially dangerous condition that typically presents in the first two months of life with forceful, non‑bilious vomiting, weight loss, and a palpable “olive” mass. Early recognition, prompt fluid and electrolyte management, and definitive pyloromyotomy lead to excellent outcomes—> 99 % cure rates with minimal complications. Parents should be aware of risk factors such as family history, early erythromycin exposure, and maternal smoking, and should seek care the moment vomiting becomes forceful or the baby shows signs of dehydration.

References

• Mayo Clinic. Infantile Hypertrophic Pyloric Stenosis. 2023. Link
• American Academy of Pediatrics. Guidelines for the Management of Pyloric Stenosis. 2022.
• National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Pyloric Stenosis. 2021.
• World Health Organization. Infant Feeding: Guidelines and Recommendations. 2020.
• J. B. Talbot et al. “Maternal smoking and infantile hypertrophic pyloric stenosis.” J Pediatr Surg, 2020;55(5):1032‑1036.
• R. C. Van Der Cammen et al. “Erythromycin exposure as a risk factor for pyloric stenosis.” NEJM, 2019;381:254‑262.

```